Background: High doses of opioids are frequently used to treat postoperative pain after spine surgery. This leads to opioid-related side effects like nausea, vomiting, respiratory depression, etc. The current study is an attempt to find a safe analgesic adjuvant, which will afford opioid sparing property.
Result: Mean pain-free periods in the ketamine group (860 min) and the dexmedetomidine group (580 min) were longer than in the saline group (265 min) (P < 0.002) during the observation period of 48 hours. There was a significant decrease in the rescue analgesic requirement in both ketamine and dexmedetomidine group (P < 0.05) (cumulative morphine requirement at 24 h-group C 15.64 ± 9.31 mg, group D 6.89 ± 5.88 mg, group K 2.45 ± 2.06 mg; at 48 h-group C 21.09 ± 12.88 mg, group D 7.98 ± 7.72 mg, group K 2.59 ± 1.97 mg). Hemodynamics were maintained within normal range in all the groups. Patients in ketamine and dexmedetomidine groups were sedated, but none required assistance for maintaining airway patency. Few patients in the ketamine group had nausea, dizziness, and diplopia, but the difference was insignificant in comparison with other groups (P > 0.05).
Conclusions: Infusion of low-dose ketamine and dexmedetomidine both provide good postoperative analgesia with minimal side effects. Both of the tested analgesic regimes can be used safely and effectively for postoperative pain relief in patients after spine surgery.
Key Words: ketamine, dexmedetomidine, spine surgery, analgesia: postoperative, pain-free period (J Neurosurg Anesthesiol 2015;00:000-000) I ntractable pain is experienced in the postoperative period after spine surgery due to extensive damage of soft tissues and muscles surrounding the vertebral column. Inadequate pain relief has been shown to contribute to adverse outcomes like delayed recovery, poor rehabilitation, and progression to chronic pain. 1, 2 Pain can even lead to immunosuppression, hyperglycemia, and deep vein thrombosis, which also affects the postsurgical results. 2 Therefore, pain management forms an essential part of postoperative care after spine surgeries.
Various analgesic treatment modalities include oral or parenteral opioids, nonsteroidal anti-inflammatory drugs, neuraxial blocks with local anesthetics with or without adjuvants with uncertain efficacy, and/or serious side effects. 3, 4 Opioids are the mainstay in postoperative pain management but are associated with respiratory depression, nausea, vomiting, etc., which increase patients' discomfort in the postoperative period.
Ketamine in small doses has been found to be a good analgesic with minimal side effects, and addition of benzodiazepine to it reduces these side effects further. 4, 5 It has analgesic action owing to the inhibition of NMDA receptor and is also known to occupy opiate receptors in the brain and spinal cord. Dexmedetomidine is a selective a 2 receptor agonist and its analgesic effect is exerted both at the spinal and supraspinal levels. Antinociceptive effect is mediated by stimulation of a 2 receptors located in locus ceruleus. 6, 7 Therefore, we planned to assess the analgesic efficacy of low-dose ketamine and dexmedetomidine infusions in patients undergoing spine surgery.
MATERIALS AND METHODS
In this prospective randomized double-blind placebo controlled study, 66 ASA physical status I or II patients, aged 18 to 60 year, scheduled to undergo elective spine surgery under general anesthesia were enrolled after getting Institute Ethical Committee approval and written informed consent from the patients. Patients with hypertension, coronary heart disease, heart block, and patients on a 2 agonist or b blockers were excluded from the study. Patients were educated about the use of Numeric Rating Scale (with 0-no pain to 10-worst imaginable pain) before surgery. All patients received a balanced anesthesia with injection morphine 0.1 mg/kg for intraoperative analgesia, propofol and vecuronium for induction, followed by maintenance with propofol, oxygen, and nitrous oxide. The study commenced in the postoperative period.
Patients were randomly allocated to the 3 groups K, D, and C by using computer-generated random numbers table and sequentially numbered opaque sealed envelope technique. The study drug infusion was started after assessing the pain score when patients were shifted to the postanesthesia care unit. Patients in group K received a bolus of ketamine 0.25 mg/kg, followed by infusion at the rate of 0.25 mg/kg/h. These patients also received midazolam 10 mg/kg bolus, followed by 10 mg/kg/h infusion through the same infusion pump (both drug's doses were adjusted in 1 syringe only). In group D, bolus of dexmedetomidine 0.5 mg/kg over 10 minutes was administered, followed by infusion at a rate of 0.3 mg/kg/h. The patient in group C received volume-matched bolus and infusion of 0.9% saline. All patients received test drug infusion for 24 hours and were monitored till 48 hours in the postoperative period. At a pain score (Numeric Rating Scale) of 4 or more, intravenous morphine 3 mg (bolus) was administered as rescue analgesic drug. The patients were monitored for hemodynamic parameters (heart rate [HR], systolic blood pressure, diastolic blood pressure [DBP]), sedation score (Modified Ramsay Sedation Score), and side effects such as nausea and vomiting, hallucination, dreaming/nightmare, diplopia, and dizziness at 0, 2, 6, 12, 18, 24, and 48 hours. Hemodynamic parameters were maintained within 20% of the baseline value with atropine (0.6 mg), esmolol (10 mg/bolus), mephentermine (3 mg/bolus), or nitroglycerine infusion (2 to 5 mg/kg/min) when needed.
Sample size for the study has been computed to compare the mean rescue analgesic doses required in ketamine and dexmedetomidine group as compared with the control group. On the basis of literature review 8 mean ± SD of analgesic dose required in the control group is morphine 69 ± 30 mg. Expecting that the analgesic dose requirement in each of the 2 groups would be 40% less than the control group, that is, 41 ± 20 mg, to detect this difference with 95% confidence level and power we needed a minimum of 18 evaluable patients in each group. Considering the attrition of data, 22 patients were enrolled in each of the groups (Fig. 1) . Statistical analysis was performed using SPSS (Chicago, IL) version 21.0 for Windows. Normality of data was checked by Kolmogorov-Smirnov test. For normally distributed data, means of quantitative variables of 3 groups were compared using 1-way analysis of variance. All quantitative variables are presented as mean and SD. Pain scores are presented as median and interquartile range, and were analyzed using the Kruskal-Wallis and further by the Mann-Whitney test. Qualitative or categorical variables are described as frequencies or proportions and were compared using the w 2 test. Pain-free interval was analyzed by survival analysis All statistical tests were 2-sided and were performed at a significance level of P < 0.05. 
RESULTS
The 3 groups were comparable with respect to demographic parameters, spine pathology, type of surgery, and vertebral levels ( Table 1) . These groups were also comparable in duration of anesthesia, amount of intravenous fluids, and blood administered.
The pain-free period was significantly longer in groups K and D compared with group C (P = 0.002) ( Table 2 ). Whereas it differed significantly between groups K and C (P = 0.001) and between groups D and C (P = 0.018), it was found to be comparable between groups K and D (P = 0.307).
Rescue morphine requirement in the postoperative period was significantly higher in group C at all times except at 0 hours. Further comparison by post hoc test showed groups C and D; and groups C and K differed significantly at all times except 0 hours (P < 0.05). Groups K and D were comparable (7.98 ± 7.724 mg for group D vs. 2.59 ± 1.974 mg for group K [P = 0.111]). Six patients in group D and only 1 patient in group K demanded for rescue analgesic (morphine) at 12 hours. The difference between groups D and K was insignificant at all other times (P > 0.05). Five patients in group D and 7 in group K did not require morphine during the study period. The morphine requirement in the first 24 hours was significantly less in group K (2.45 ± 2.067 mg) and group D (6.89 ± 5.886 mg) as compared with group C (15.64 ± 9.31 mg) ( Table 2) .
Pain score was significantly decreased (P < 0.05) in active drug groups compared with group C except immediately after surgery (0 h). It was least in group K and was comparable to group D except at 6 hours (Table 3) .
HR was significantly decreased after starting the study drugs except in group C in which it remained high but only for 2 hours. No significant difference was found in HR between group K and group D (Fig. 2) . Systolic blood pressure and diastolic blood pressure were significantly increased in group C compared with the drug groups (P = 0.001) except at 0 hour (Fig. 3) . No patient required any rescue drug for maintaining hemodynamics.
The sedation score in the 3 groups differed significantly except at 0 and 48 hours. However, not a single patient required assistance for maintaining airway. Postoperative complications like nausea, vomiting, diplopia, and dizziness were comparable in all 3 groups (P > 0.05) 
DISCUSSION
Postoperative pain is a major complaint of patients after spine surgery. Opioid analgesia may lead to many untoward side effects delaying discharge of patients. Both ketamine and dexmedetomidine have analgesic property, and opioid sparing properties of the 2 were compared in this trial. The study demonstrated that ketamine decreased morphine requirement by 74%, whereas dexmedetomidine decreased it by 54%. Zakine et al 8 suggested that the morphine sparing effect of ketamine could also be due to its central antihyperalgesic effect.
The ketamine group showed the least pain score. This analgesic effect has been attributed to its antagonist action on the NMDA receptor. Tissue injury that results in the sensitization of the central nociceptive system is also partly mediated by NMDA receptors and is abolished by ketamine. Hadi et al 9 also found a significant decrease in the visual analog scale score in the ketamine group when used in lumbar microdiscectomy surgery. Ketamine results in long-lasting postoperative analgesia, extending well beyond the administration period. 10 The dexmedetomidine group showed an intermediate pain score, which were significantly better than those of the control group. The analgesic effect of dexmedetomidine is through its action on the dorsal horn of the spinal cord. Kim et al 11 used dexmedetomidine and observed significant decrease in pain score and dose of patient controlled analgesia (PCA) fentanyl (47 vs. 83 mg) in comparison with control. Arain et al 12 gave dexmedetomidine intraoperatively and 4 hours postoperatively and found a decrease in morphine requirement by 66% in the dexmedetomidine group.
In this study the time to first requirement of morphine was longest for the ketamine group (860 min) than the dexmedetomidine group (580 min) and the control group (265 min). Hadi et al 9 also noted that the time to the first patient's analgesia request in postanesthesia care unit was more in patients receiving ketamine both intraoperatively and postoperatively compared with placebo.
Dexmedetomidine has been known to produce "arousable sedation," that is, the patient remains sedated but responds to verbal instruction. Currently, FDA approves its use for intensive care unit sedation for 24 hours only, which was also followed in our study. Its sedative action is by central action on locus ceruleus. 6, 7, 13 Although dexmedetomidine and ketamine provide sedation, we found that administration of either of them did not result in excessive sedation mandating any intervention.
All patients in our study were hemodynamically stable during the study period. Hemodynamic changes after dexmedetomidine administration are complex. It produces transient hypertension caused by direct vasoconstriction, followed by hypotension and bradycardia. 13 Dexmedetomidine also decreases HR and blood pressure in a dose-dependent manner. 14, 15 It activates inhibitory neurons in the medullary vasomotor center and reduces plasma catecholamine concentration. 14, 16, 17 To prevent significant hemodynamic effects, we used low dose of dexmedetomidine (loading dose 0.5 mg/kg over 10 min, followed by infusion of 0.3 mg/kg/h). Ketamine produces an increase in blood pressure, stroke volume, and HR. These effects peak in about 2 minutes after intravenous administration and settle over 15 to 20 minutes and are dose dependent. There may be wide variation in individual response, and occasionally there can be a sudden increase in blood pressure, even in normotensive patients. These responses of ketamine are mediated centrally and the use of a centrally depressant agent such as benzodiazepines can blunt this effect. 4, 5 Therefore, in our study we did not observe either increase in HR or blood pressure probably due to concomitant infusion of midazolam. Ketamine is known to cause psychomimetic effect. Studies in the past have proposed that ketamine causes hallucination due to inhibition of cholinergic pathways and excitation of central nervous system particularly the frontal lobe. 17, 18 Hallucination can be decreased by premedication with benzodiazepines like midazolam as has been used in our study. 19 There were no reported cases of hallucination in our study.
There are few limitations in this study. We have monitored the patients only in the postoperative period. There was no record of their severity of preoperative pain. Diseases like chronic backache with prolapsed disk pathology would have more analgesic requirement due to preoperative sensitization. PCA provides a better pain relief and improves patient satisfaction than a fixed rate infusion of the drugs. But we did not use study drug in PCA.
Thus, we conclude that both ketamine and dexmedetomidine in small infusions provides good and safe analgesia, decreasing morphine requirement and increasing the pain-free period during the postoperative period.
